These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27102824)

  • 1. Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton.
    Yorgan T; Vollersen N; Riedel C; Jeschke A; Peters S; Busse B; Amling M; Schinke T
    Bone; 2016 Jun; 87():136-46. PubMed ID: 27102824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
    Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
    J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
    Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
    J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides targeting
    Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
    J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
    Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
    J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
    Yu J; Schilling L; Eller T; Canalis E
    J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice.
    Canalis E; Sanjay A; Yu J; Zanotti S
    Endocrinology; 2017 Apr; 158(4):730-742. PubMed ID: 28323963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
    Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG
    J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
    Yu J; Canalis E
    J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice.
    Youngstrom DW; Dishowitz MI; Bales CB; Carr E; Mutyaba PL; Kozloff KM; Shitaye H; Hankenson KD; Loomes KM
    Bone; 2016 Oct; 91():64-74. PubMed ID: 27416809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation.
    Lee SY; Long F
    J Clin Invest; 2018 Dec; 128(12):5573-5586. PubMed ID: 30284985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture.
    Zanotti S; Canalis E
    Bone; 2014 May; 62():22-8. PubMed ID: 24508387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of the Progesterone Receptor in Mx1+ Cells Potentiates Osteogenesis in Calvaria but Not in Long Bone.
    Zhong ZA; Sun W; Chen H; Zhang H; Lane NE; Yao W
    PLoS One; 2015; 10(10):e0139490. PubMed ID: 26431032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts.
    Ucer S; Iyer S; Bartell SM; Martin-Millan M; Han L; Kim HN; Weinstein RS; Jilka RL; O'Brien CA; Almeida M; Manolagas SC
    J Bone Miner Res; 2015 Jul; 30(7):1138-49. PubMed ID: 25704845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast lineage-specific effects of notch activation in the skeleton.
    Canalis E; Parker K; Feng JQ; Zanotti S
    Endocrinology; 2013 Feb; 154(2):623-34. PubMed ID: 23275471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
    Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
    Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.
    Canalis E; Adams DJ; Boskey A; Parker K; Kranz L; Zanotti S
    J Biol Chem; 2013 Aug; 288(35):25614-25625. PubMed ID: 23884415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hajdu-Cheney syndrome: a review.
    Canalis E; Zanotti S
    Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
    Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
    J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.
    Kim HJ; Minashima T; McCarthy EF; Winkles JA; Kirsch T
    J Bone Miner Res; 2010 Aug; 25(8):1771-83. PubMed ID: 20200976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.